Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone CLB-IVC7] (IgG1) to Human CD36
Mouse Monoclonal [clone VM58] (IgG1,k) to Human CD36
IHC, Immunofluorescence, Flow Cytometry
Human (tested or 100% immunogen sequence identity)
IgG1,k Monoclonal [VM58]
Ammonium sulfate precipitation
Specificity and Use
CD36 antibody was raised against human CD36.
Recognizes human CD36 at ~90kD, platelets, monocytes, macrophages, erythroblasts and (weakly) with B-cells. In immunohistology the monoclonal antibody recognizes some endothelial cells, adipocytes and the granular layer of the skin.
Suitable for use in Immunofluorescence, Flow Cytometry and Immunohistochemistry. Immunofluorescence: 1% paraformaldehyde for 5 min.
Lyophilized from in PBS, sodium azide
1,000 µl Distilled Water.
Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Reconstituted product is stable for 6 months at -20°C.
Binds to collagen, thrombospondin, anionic phospholipids and oxidized low-density lipoprotein (oxLDL). May function as a cell adhesion molecule. Directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Receptor for thombospondins, THBS1 AND THBS2, mediating their antiangiogenic effects.